Insmed
INSM
#542
Rank
โ‚ฌ37.36 B
Marketcap
175,22ย โ‚ฌ
Share price
-0.51%
Change (1 day)
145.52%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: โ‚ฌ37.36 Billion

As of December 2025 Insmed has a market cap of โ‚ฌ37.36 Billion. This makes Insmed the world's 542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ37.36 B212.26%
2024โ‚ฌ11.96 B198.4%
2023โ‚ฌ4.01 B58.93%
2022โ‚ฌ2.52 B-11.37%
2021โ‚ฌ2.84 B3.27%
2020โ‚ฌ2.75 B44.22%
2019โ‚ฌ1.91 B115.63%
2018โ‚ฌ0.88 B-55.45%
2017โ‚ฌ1.99 B155.73%
2016โ‚ฌ0.77 B-24.15%
2015โ‚ฌ1.02 B61.96%
2014โ‚ฌ0.63 B31.5%
2013โ‚ฌ0.48 B202.52%
2012โ‚ฌ0.15 B173.05%
2011โ‚ฌ58.32 M-21.44%
2010โ‚ฌ74.23 M6.08%
2009โ‚ฌ69.97 M71.09%
2008โ‚ฌ40.9 M-40.62%
2007โ‚ฌ68.87 M1.93%
2006โ‚ฌ67.57 M-38.92%
2005โ‚ฌ0.11 B52.02%
2004โ‚ฌ72.77 M-19.65%
2003โ‚ฌ90.57 M535.42%
2002โ‚ฌ14.25 M-89.99%
2001โ‚ฌ0.14 B17.94%
2000โ‚ฌ0.12 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Insmed was reported to be:

โ‚ฌ37.36 Billion
by Nasdaq info icon info icon
โ‚ฌ37.36 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ2.00 B-94.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ217.80 B 482.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ129.18 B 245.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ1.03 B-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.64 B-98.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ100.30 B 168.41%๐Ÿ‡บ๐Ÿ‡ธ USA